IL250592D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
IL250592D0
IL250592D0 IL250592A IL25059217A IL250592D0 IL 250592 D0 IL250592 D0 IL 250592D0 IL 250592 A IL250592 A IL 250592A IL 25059217 A IL25059217 A IL 25059217A IL 250592 D0 IL250592 D0 IL 250592D0
Authority
IL
Israel
Prior art keywords
novel compounds
compounds
novel
Prior art date
Application number
IL250592A
Other languages
Hebrew (he)
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB1417002.1A priority Critical patent/GB201417002D0/en
Priority to PCT/EP2015/071776 priority patent/WO2016046225A1/en
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of IL250592D0 publication Critical patent/IL250592D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
IL250592A 2014-09-26 2017-02-14 Novel compounds IL250592D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1417002.1A GB201417002D0 (en) 2014-09-26 2014-09-26 Novel compound
PCT/EP2015/071776 WO2016046225A1 (en) 2014-09-26 2015-09-22 Novel compounds

Publications (1)

Publication Number Publication Date
IL250592D0 true IL250592D0 (en) 2017-04-30

Family

ID=51901158

Family Applications (1)

Application Number Title Priority Date Filing Date
IL250592A IL250592D0 (en) 2014-09-26 2017-02-14 Novel compounds

Country Status (29)

Country Link
US (2) US9956209B2 (en)
EP (2) EP3428167A1 (en)
JP (1) JP2017528507A (en)
KR (1) KR20170055489A (en)
CN (1) CN107074848A (en)
AR (1) AR101994A1 (en)
AU (1) AU2015320858B2 (en)
BR (1) BR112017006251A2 (en)
CA (1) CA2962315A1 (en)
CL (1) CL2017000705A1 (en)
CR (1) CR20170112A (en)
DK (1) DK3197892T3 (en)
DO (1) DOP2017000081A (en)
EA (1) EA031481B1 (en)
ES (1) ES2690748T3 (en)
GB (1) GB201417002D0 (en)
HR (1) HRP20181796T1 (en)
IL (1) IL250592D0 (en)
LT (1) LT3197892T (en)
MA (1) MA40580B1 (en)
MX (1) MX2017003948A (en)
PE (1) PE05022017A1 (en)
PH (1) PH12017500361A1 (en)
RS (1) RS58000B1 (en)
SG (1) SG11201701183YA (en)
SI (1) SI3197892T1 (en)
TW (1) TW201629056A (en)
UY (1) UY36314A (en)
WO (1) WO2016046225A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201305668D0 (en) 2013-03-28 2013-05-15 Glaxosmithkline Ip Dev Ltd Avs6 Integrin Antagonists
GB201417011D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417002D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compound
GB201417094D0 (en) * 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417018D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201604681D0 (en) 2016-03-21 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical Compounds
GB201604680D0 (en) * 2016-03-21 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical Compounds
WO2018089358A1 (en) 2016-11-08 2018-05-17 Bristol-Myers Squibb Company Azole amides and amines as alpha v integrin inhibitors
WO2018089353A1 (en) 2016-11-08 2018-05-17 Bristol-Myers Squibb Company 3-substituted propionic acids as alpha v integrin inhibitors
WO2018089360A1 (en) 2016-11-08 2018-05-17 Bristol-Myers Squibb Company Pyrrole amides as alpha v integrin inhibitors
WO2018089357A1 (en) 2016-11-08 2018-05-17 Bristol-Myers Squibb Company INDAZOLE DERIVATIVES AS αV INTEGRIN ANTAGONISTS
TW201819378A (en) 2016-11-08 2018-06-01 Squibb Bristol Myers Co Cyclobutane- and azetidine-containing mono and spirocyclic compounds as [alpha]v integrin inhibitors
WO2018167295A1 (en) * 2017-03-17 2018-09-20 Technische Universität München LIGANDS FOR INTEGRIN αvβ8, SYNTHESIS AND USES THEREOF

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200000362A (en) 1997-12-17 2001-12-17 Merck & Co., Inc. Integrin receptor antagonists, pharmaceutical composition and method of manufacture
AU736026B2 (en) 1997-12-17 2001-07-26 Merck & Co., Inc. Integrin receptor antagonists
WO2000072801A2 (en) 1999-06-02 2000-12-07 Merck & Co., Inc. Alpha v integrin receptor antagonists
AU748949B2 (en) 1999-06-23 2002-06-13 Merck & Co., Inc. Integrin receptor antagonists
AU7743400A (en) * 1999-10-04 2001-05-10 Merck & Co., Inc. Integrin receptor antagonists
CN1414966A (en) 1999-11-08 2003-04-30 麦克公司 Process and intermediates for preparation of imidazolidinone alpha U protein antagonists
US6933304B2 (en) 2000-06-15 2005-08-23 Pharmacia Corporation Heteroarylalkanoic acids as integrin receptor antagonists
US6921767B2 (en) 2000-06-15 2005-07-26 Pharmacia Corporation Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
AU7793501A (en) 2000-07-26 2002-02-05 Merck & Co Inc Alpha v integrin receptor antagonists
AU9077201A (en) 2000-09-14 2002-03-26 Merck & Co Inc Alpha v integrin receptor antagonists
EP1349548A4 (en) 2001-01-03 2004-06-02 Merck & Co Inc Methods and compositions for treating periodontal disease
DE10112771A1 (en) 2001-03-16 2002-09-26 Merck Patent Gmbh New 3-acylamino-3-phenyl-propionic acid derivatives, are integrin inhibitors useful e.g. for treating thrombosis, cardiac infarction, angina pectoris, tumor diseases, inflammation, osteoporosis or infections
MY147019A (en) 2002-03-13 2012-10-15 Biogen Idec Inc Anti-alpha v beta 6 antibodies
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
BR0317600A (en) 2002-12-20 2005-11-29 Pharmacia Corp heteroarilalcanóicos acid derivatives as integrin receptor antagonists
US6932865B2 (en) 2003-04-11 2005-08-23 Lockheed Martin Corporation System and method of making single-crystal structures through free-form fabrication techniques
WO2008118455A1 (en) 2007-03-23 2008-10-02 Amgen Inc. δ3- SUBSTITUTED QUINOLINE OR QUINOXALINE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE ( PI3K) INHIBITORS
WO2009055418A1 (en) 2007-10-22 2009-04-30 Smithkline Beecham Corporation Pyridosulfonamide derivatives as pi3 kinase inhibitors
WO2011111880A1 (en) 2010-03-08 2011-09-15 주식회사 메디젠텍 Pharmaceutical composition for treating or preventing diseases caused by the nuclear export of gsk3, including a compound for inhibiting the nuclear export of gsk3
GB201305668D0 (en) * 2013-03-28 2013-05-15 Glaxosmithkline Ip Dev Ltd Avs6 Integrin Antagonists
AU2014324426A1 (en) 2013-09-30 2016-04-21 The Regents Of The University Of California Anti-alphavbeta1 integrin compounds and methods
GB201417002D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compound
GB201417094D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417011D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417018D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
US9790222B2 (en) 2015-02-19 2017-10-17 Scifluor Life Sciences, Inc. Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
JP2018515424A (en) 2015-03-10 2018-06-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Anti-alpha v beta 1 integrin inhibitors and methods of use
GB201604589D0 (en) 2016-03-18 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical compound
GB201604680D0 (en) 2016-03-21 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical Compounds

Also Published As

Publication number Publication date
WO2016046225A1 (en) 2016-03-31
PH12017500361A1 (en) 2017-07-17
EP3197892A1 (en) 2017-08-02
TW201629056A (en) 2016-08-16
CN107074848A (en) 2017-08-18
US20170290817A1 (en) 2017-10-12
US20180271845A1 (en) 2018-09-27
AR101994A1 (en) 2017-01-25
GB201417002D0 (en) 2014-11-12
EA201790715A1 (en) 2017-07-31
HRP20181796T1 (en) 2018-12-28
EP3197892B1 (en) 2018-09-05
EA031481B1 (en) 2019-01-31
UY36314A (en) 2016-04-29
SG11201701183YA (en) 2017-04-27
RS58000B1 (en) 2019-01-31
EP3428167A1 (en) 2019-01-16
KR20170055489A (en) 2017-05-19
ES2690748T3 (en) 2018-11-22
PE05022017A1 (en) 2017-04-27
BR112017006251A2 (en) 2017-12-12
AU2015320858A1 (en) 2017-03-09
US9956209B2 (en) 2018-05-01
MX2017003948A (en) 2017-06-26
AU2015320858B2 (en) 2018-10-18
CA2962315A1 (en) 2016-03-31
JP2017528507A (en) 2017-09-28
MA40580B1 (en) 2018-09-28
CL2017000705A1 (en) 2017-11-03
DK3197892T3 (en) 2018-11-26
LT3197892T (en) 2018-12-10
SI3197892T1 (en) 2018-12-31
CR20170112A (en) 2017-05-26
DOP2017000081A (en) 2017-04-30

Similar Documents

Publication Publication Date Title
HK1217861A1 (en) Wifi-coordinated laa-lte
SG11201700847YA (en) Novel compounds
GB201501462D0 (en) Novel compounds
GB201417002D0 (en) Novel compound
GB201410907D0 (en) No details
GB201417011D0 (en) Novel compounds
GB201404893D0 (en) Selfie - Stick
TWI583681B (en) Aminopyrimidinyl compounds
GB201417094D0 (en) Novel compounds
GB201402431D0 (en) Compounds
SG11201605342UA (en) Compounds
TWI582083B (en) Aminopyridyloxypyrazole compounds
GB201417018D0 (en) Novel compounds
GB201418300D0 (en) Compounds
EP3325449A4 (en) Compounds
GB201419094D0 (en) Anti-TIM-3-antibodies
GB201418217D0 (en) No details
GB201506871D0 (en) Novel compounds
TWI561516B (en) Substituted dihydroisoquinolinone compounds
GB201404498D0 (en) New compounds
GB201409044D0 (en) New compounds
GB201410430D0 (en) Compounds
SG11201609722UA (en) Novel compounds
SG11201606693SA (en) Novel compounds
GB2528557B (en) Soundbar